In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Corteva's current price slightly exceeds its PERT-weighted fair value, reflecting mild overvaluation with high confidence. Monte Carlo analysis shows extreme volatility and significant downside risk (68.6%), despite a high expected value driven by a broad growth/WACC range. Weak profitability and growth scores increase fundamental risk amid valuation disparities.